论文部分内容阅读
重症肝炎是病毒性肝炎中予后最严重的一类,其发病机理尚未完全阐明。治疗方法很多,效果均不满意。1971年 Pake 氏提出用大剂量肝素治疗暴发性肝炎以来,国内外均陆续有类似报告。但大剂量应用肝素,需要严密的化验室监护,否则有引起大出血的危险。而这种严密的化验监护,在一般较基层的医院目前还难以做到。为了探索一个简便、安全而有效的肝素治疗方法,我科从1976年10月起,应用每天100mg 的小剂量肝素治疗了重症肝炎26例,取得初步效果。今将其临床情况报告如下:
Severe hepatitis is the most severe type of viral hepatitis, the pathogenesis has not been fully elucidated. A lot of treatment, the results are not satisfied. Pake’s 1971 proposed high-dose heparin in the treatment of fulminant hepatitis, both at home and abroad have been a similar report. However, high-dose heparin, the need for close laboratory monitoring, or have the risk of causing bleeding. This strict laboratory monitoring, in the general than the grass-roots hospitals are still difficult to achieve. In order to explore a simple, safe and effective heparin treatment, our department from October 1976 onwards, the application of small doses of heparin 100mg daily treatment of severe hepatitis in 26 cases, and achieved initial results. The clinical situation now report as follows: